Release date: 2015-11-25
Research and consulting firm GlobalData pointed out in a recent report that the global women's health equipment market is expected to grow at a compound annual growth rate (CAGR) of 3.7% in the next few years, from $1.8 billion in 2014 to $2.4 billion in 2021. .
GlobalData said in the report that the growth trend of the global women's health equipment market will mainly appear in the following 10 major markets: the United States, India, Brazil, China, France, Germany, Italy, Spain, the United Kingdom, and Japan. Among the major factors driving the growth of the market include the growing awareness of doctors and patients about minimally invasive techniques, the increasing number of women seeking treatment for reproductive health and pelvic health-related diseases, and the rising incidence of related diseases.
Premdharan Meyyan, GlobalData Medical Device Analyst, said the number of patients seeking treatment for reproductive and women's health-related diseases is increasing, largely due to the fact that people are beginning to realize that these diseases have brought about women's quality of life. Great impact.
Meyyan pointed out that people began to realize that women's quality of life can be greatly improved through new technologies, while also recognizing a series of new treatments, such as endometrial resection and uterine artery embolization, compared to traditional surgery. It has minimal invasiveness. For women with severe uterine bleeding such as severe menstrual bleeding and uterine leiomyoma, these new technologies undoubtedly provide a safe and effective treatment for patients who are unwilling to undergo invasive surgery.
Analyst Meyyan said that as more women seek treatment for problems such as uterine health and incontinence, the competition in the women's health market is becoming more intense, and it has also proved that these new technologies have achieved certain effects. Meet safety standards.
Meyyan continues: “Although the updated technology has the potential to revolutionize the women's healthcare market, more powerful clinical data must be established before the women's health equipment can expand normally. In addition, during the forecast period, these The high price of new therapies may also be an obstacle to market growth."
Source: New Kangjie
Functional oligosaccharides refer to oligosaccharides that are difficult or impossible to be digested and absorbed by the human body and have special physiological effects on the human body. Its sweetness is generally only 30-50% of that of sucrose, and it has physiological functions such as low-calorie, anti-caries, prevention and treatment of diabetes, and improvement of intestinal colony structure. Due to the special physiological functions of functional oligosaccharides, it becomes a nutrient and health care product. A new generation of food-effect raw materials that integrate diet and therapy. It is a new functional sugar source that replaces sucrose and has a wide range of uses and application prospects. Common functional oligosaccharides include: xylo-oligosaccharides, fructooligosaccharides, galacto-oligosaccharides, isomaltose, raffinose and so on.
XOS, GOS, FOS, IMO, Raffinose, oligosaccharide
Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualynbio.com